Seres Therapeutics, Inc. (MCRB) NASDAQ

9.13

+0.33(+3.75%)

Updated at March 04 04:00PM

Currency In USD

Valuation

Market Cap129.14M
Enterprise Value189.99M
P/E Ratio15.05
PEG Ratio0.14
Price/Sales Ratio238.92
Price/Book Ratio1.86
Enterprise/Revenue346.09
Enterprise/EBITDA12.56

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin15.37
Operating Margin-294.67

Management Effectiveness

Return On Assets0.04
Return On Equity0.15

Income Statement

Revenue0
Revenue/Share0.04
Gross Profit-3.53M
EBITDA-120.3M
Net Income136,000
Diluted EPS-18.86

Balance Sheet

Total Cash47.64M
Total Cash/Share5.44
Total Debt85.25M
Total Debt/Equity1.95
Current Ratio2.3
Book Value Per Share4.99

Price History

52-Week Change-30.82
52-Week High29.98
52-Week Low6.53
Moving Average 50 Days13.38
Moving Average 200 Days14.58

Statistics

Average Volume75,700
Shares Outstanding9.05M
% Held by Institutions27.88

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:20
Last Split DateApril 22, 2025